(MENAFN - Muscat Daily) Badr al Samaa healthcare group, in association with Sanofi, recently organised a continuing medical education programme (CME) at Crowne Plaza Muscat.
The lecture discussed respiratory tract infection and urinary tract infection management with role of fluoroquinolones and updates on the use of levofloxacin in RTIs and UTIs. The speaker, Dr Adrian Brink, is a clinical microbiologist at Ambath National Laboratory Services, Milpark Hospital, Johannesburg.
The lecture discussed the efficacy of levofloxacin on sinusitis, pneumonia and urinary tract infections. Dr Brink has given several presentations at national and international congresses, and has authored or co-authored 40 papers, which has appead in journals like the International Journal of Antimicrobial Agents, Emerging Infectious Diseases and the Journal of Antimicrobial Chemotherapy.
His research interests include antibiotic resistance in community- acquired infections and intensive- care-related infections, as well as the pharmacokinetics and outcome measures of antibiotics in healthcare-associated infections, ICU-related in particular. Queries raised by the attending doctors were answered by Dr Brink in the open interactive session.
Basem, product manager, Sanofi, welcomed the gathering and Rania, manager medical department, proposed a vote of thanks. The CME programme was attended by around 80 doctors from different specialties in and around Muscat.